Avalyn Pharma director awarded 26,978 stock options
Avalyn Pharma Inc. director Kate Haviland received a new stock option grant covering 26,978 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Avalyn Pharma Inc. director Kate Haviland received a new stock option grant covering 26,978 shares of common stock. The option has an exercise price of $18.00 per share and expires on April 28, 2036.
This award is compensation-related, not an open-market trade. According to the vesting terms, 25% of the shares underlying the option vest on September 12, 2025, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to her continued service. Following this grant, she holds 26,978 stock options directly from this award.
Insider Trade Summary
Grant/Award: 26,978 shares
Grant/Award
1 txn
Insider
Haviland Kate
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 26,978 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 26,978 contracts (Direct)
Footnotes (1)
- F1. 25% of the shares underlying this option vest and become exercisable on September 12, 2025, with the remaining 75% vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
Key Figures
Option grant size: 26,978 options
Exercise price: $18.00 per share
Expiration date: April 28, 2036
+3 more
6 metrics
Option grant size
26,978 options
Stock Option (Right to Buy) granted to director
Exercise price
$18.00 per share
Conversion or exercise price of stock option
Expiration date
April 28, 2036
Option expiration date
Post-transaction options
26,978 options
Total derivative securities following transaction
Initial vesting tranche
25% of shares
Vesting on September 12, 2025
Remaining vesting schedule
75% over 36 months
Monthly vesting after September 12, 2025
Key Terms
Stock Option (Right to Buy), exercise price, vesting, derivative securities, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 18.0000"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"25% of the shares underlying this option vest and become exercisable"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
derivative securities financial
"derivativeTransactionCount: 1"
Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.
expiration date financial
"expiration_date: 2036-04-28T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Avalyn Pharma (AVLN) director Kate Haviland report on this Form 4?
Kate Haviland reported receiving a stock option grant for 26,978 Avalyn Pharma shares. The award is a compensation-related option, not an open-market stock purchase or sale, and gives her the right to buy common shares at a fixed exercise price.
What is the exercise price and expiration date of Kate Haviland’s Avalyn Pharma option?
The option has an exercise price of $18.00 per share and expires on April 28, 2036. This means she can choose to buy Avalyn Pharma shares at $18.00, once vested, any time before the 2036 expiration date stated in the grant.
How does the Avalyn Pharma (AVLN) stock option granted to Kate Haviland vest?
Vesting occurs over time: 25% of the shares underlying the option vest on September 12, 2025. The remaining 75% then vest in 36 equal monthly installments, contingent on her continued service on each scheduled vesting date as described.
Is Kate Haviland’s Avalyn Pharma Form 4 a stock purchase or sale?
The Form 4 reports a stock option grant, not a stock purchase or sale in the open market. The transaction is coded as a grant or award, giving her the right to buy shares later rather than reflecting an immediate buy or sell transaction.
How many Avalyn Pharma options does Kate Haviland hold after this grant?
Following this reported transaction, she holds 26,978 stock options from the award. This figure reflects the total derivative securities from this specific grant shown, with the options subject to the vesting schedule and future exercise decisions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
